World's Best Scientists 2026 revealed!
Jordi Carratalà

Jordi Carratalà

D-Index & Metrics

Medicine

D-Index
90
Citations
29377
World Ranking
12217
National Ranking
173

Jordi Carratalà publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jordi Carratalà sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 467 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jordi Carratalà D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jordi Carratalà sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jordi Carratalà is affiliated with the University of Barcelona in Spain and has contributed extensively to research in the field of medicine, with a particular focus on epidemiology and infectious diseases. Their work spans several subfields including oncology, neurology, and pharmacology. The research topics they have addressed cover diverse aspects of infectious diseases, with particular attention to COVID-19 and antibiotic-related studies.

The scientist's recent research papers include:

  • Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain, 2020, Clinical Microbiology and Infection
  • Immunological imprinting of the antibody response in COVID-19 patients, 2021, Nature Communications
  • Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern, 2020, Infection Control and Hospital Epidemiology
  • Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial, 2020, Clinical Infectious Diseases
  • Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19), 2020, Clinical Microbiology and Infection

Carratalà frequently publishes in several scientific journals, including:

  • Clinical Microbiology and Infection
  • Antibiotics
  • Clinical Infectious Diseases
  • Journal of Infection
  • Open Forum Infectious Diseases

Within the scope of collaboration, the scientist has coauthored extensively with colleagues such as Carlota Gudiol, Gabriela Abelenda-Alonso, Cristian Tebé, Alexander Rombauts, and Natàlia Pallarès.

Their main topics of work encompass:

  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Pneumonia and Respiratory Infections
  • Antibiotics Pharmacokinetics and Efficacy
  • Neutropenia and Cancer Infections
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing

Jordi Carratalà's academic output includes over 300 publications within the field of medicine, with particular concentration in epidemiology and infectious diseases. Their work addresses critical issues ranging from antimicrobial resistance to COVID-19 patient management, contributing to clinical knowledge and pharmacological research.

Best Publications

  • Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

    Andre C. Kalil;Mark L. Metersky;Michael Klompas;John Muscedere

  • Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

    Stella G Muthuri;Sudhir Venkatesan;Puja R Myles;Jo Leonardi-Bee

  • Health Care–Associated Pneumonia Requiring Hospital Admission: Epidemiology, Antibiotic Therapy, and Clinical Outcomes

    Jordi Carratalà;Analía Mykietiuk;Núria Fernández-Sabé;Cristina Suárez

  • Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.

    J. Berenguer;P. Ryan;J. Rodríguez-Baño;I. Jarrín

  • Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia

    Beatriz Rosón;Jordi Carratalà;Núria Fernández-Sabé;Fe Tubau

  • Tuberculosis after Solid-Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort

    Julián Torre-Cisneros;Antonio Doblas;José María Aguado;Rafael San Juan

  • Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes.

    Núria Fernández-Sabé;Jordi Carratalà;Beatriz Rosón;Jordi Dorca

  • Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients

    C. Gudiol;C. Gudiol;M. Bodro;M. Bodro;A. Simonetti;F. Tubau

  • Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization

    Beatriz Rosón;Jordi Carratalà;Ricard Verdaguer;Jordi Dorca

  • Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients.

    Jordi Carratalà;Núria Fernández-Sabé;Lucía Ortega;Xavier Castellsagué

  • Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes

    C Gudiol;C Gudiol;F Tubau;F Tubau;L Calatayud;L Calatayud;C Garcia-Vidal;C Garcia-Vidal

  • Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community-Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria

    Beatriz Rosón;Jordi Carratalà;Jordi Dorca;Aurora Casanova

  • Contribution of a Urinary Antigen Assay (Binax NOW) to the Early Diagnosis of Pneumococcal Pneumonia

    Beatriz Rosón;Nuria Fernández-Sabé;Jordi Carratalà;Ricard Verdaguer

  • Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain.

    A. Moreno;C. Cervera;J. Gavaldá;M. Rovira

  • Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

    Carlota Gudiol;Carlota Gudiol;Laura Calatayud;Carolina Garcia-Vidal;Carolina Garcia-Vidal;Jaime Lora-Tamayo;Jaime Lora-Tamayo

  • Factors Associated with Complications and Mortality in Adult Patients Hospitalized for Infectious Cellulitis

    J. Carratalà;B. Rosón;N. Fernández-Sabé;E. Shaw

  • Randomized, Double-Blind Trial of an Antibiotic-Lock Technique for Prevention of Gram-Positive Central Venous Catheter-Related Infection in Neutropenic Patients with Cancer

    Jordi Carratalà;Jordi Niubó;Alberto Fernández-Sevilla;Eulalia Juvé

  • Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

    Jordi Carratalá;Alberto Fernández-Sevilla;Fe Tubau;Manuel Callis

  • Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

    Manuela Aguilar-Guisado;Ildefonso Espigado;Almudena Martín-Peña;Carlota Gudiol

  • Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    E. Vidal;J. Torre-Cisneros;M. Blanes;M. Montejo

Frequent Co-Authors

Patricia Muñoz
Patricia Muñoz Hospital General Universitario Gregorio Marañón
Francisco Gudiol
Francisco Gudiol University of Barcelona
Fe Tubau
Fe Tubau Bellvitge University Hospital
Jesús Rodríguez-Baño
Jesús Rodríguez-Baño University of Seville
Carmen Ardanuy
Carmen Ardanuy Bellvitge University Hospital
Josefina Liñares
Josefina Liñares University of Barcelona
Jerónimo Pachón
Jerónimo Pachón University of Seville
Leonard Leibovici
Leonard Leibovici Tel Aviv University
Javier Pemán
Javier Pemán Hospital Universitari i Politècnic La Fe
Francesc Marco
Francesc Marco University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of rewarding health professions. For students seeking flexibility, online health degrees offer an accessible pathway. Prospective nurses can start their journey through cheapest bsn programs online, designed to balance affordability with quality education.

Registered Nurses who wish to advance their qualifications can benefit from cheap rn to bsn programs. These bridge programs allow working professionals to upgrade efficiently while minimizing costs and schedule disruptions.

For those aiming higher, advanced roles in nursing education or research are attainable with phd in nursing online programs. These flexible doctorates are ideal for clinicians interested in shaping the future of healthcare.

If you already hold a non-nursing bachelor’s degree, direct entry msn programs online provide an accelerated route to becoming a registered nurse and earning a master’s credential.

Online pathways make it easier than ever to enter or advance within the healthcare field, offering options tailored to your background and career goals.

Best Scientists Citing Jordi Carratalà

Trending Scientists

Recently Published Articles